![Shu Feng Zhang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Shu Feng Zhang
Chairman at Beijing Biostar Pharmaceuticals Co. Ltd.
Shu Feng Zhang active positions
Companies | Position | Start | End |
---|---|---|---|
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | Chairman | 01/03/2021 | - |
Director/Board Member | 17/02/2016 | 01/03/2021 |
Career history of Shu Feng Zhang
Training of Shu Feng Zhang
Tsinghua University | Masters Business Admin |
Statistics
International
China | 3 |
Operational
Masters Business Admin | 1 |
Director/Board Member | 1 |
Chairman | 1 |
Sectoral
Consumer Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | Health Technology |
- Stock Market
- Insiders
- Shu Feng Zhang
- Experience